All
Results: 1789-1800 of 58674

Novo Nordisk's Wegovy® (semaglutide 2.4 mg) was associated with liver health-related benefits not solely based on weight loss in adult patients with MASH with liver scarring, according to a new post hoc analysis

Abu Dhabi Investment Office announces 29 strategic partnerships to accelerate commercialisation of autonomous mobility

Halia Therapeutics to Present Groundbreaking Data on Novel Allosteric NEK7 Inhibitor Ofirnoflast at the 2025 American Society of Hematology Annual Meeting

Clio Completes Landmark $1B vLex Acquisition and Announces $500M Series G Funding Round at $5B Valuation







